Vonoprazan
VONO-401
Phase 3 small_molecule completed
Quick answer
Vonoprazan for Erosive Esophagitis is a Phase 3 program (small_molecule) at Phathom Pharmaceuticals with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Phathom Pharmaceuticals
- Indication
- Erosive Esophagitis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed